2010
DOI: 10.1016/j.vaccine.2010.03.043
|View full text |Cite
|
Sign up to set email alerts
|

Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
28
1
1

Year Published

2011
2011
2020
2020

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 39 publications
(32 citation statements)
references
References 11 publications
1
28
1
1
Order By: Relevance
“…To overcome this issue, research in recent years has focused on the use of the mucosal immune system for vaccination. Intranasal vaccination against BRSV proved effective in challenge studies in calves without maternal antibodies [104][105][106][107]. In calves with maternal antibodies against BRSV, protective effect of intranasal vaccination compared to an unvaccinated control group was confirmed in two studies [106,108].…”
Section: Specific Prevention (Vaccination)mentioning
confidence: 91%
See 1 more Smart Citation
“…To overcome this issue, research in recent years has focused on the use of the mucosal immune system for vaccination. Intranasal vaccination against BRSV proved effective in challenge studies in calves without maternal antibodies [104][105][106][107]. In calves with maternal antibodies against BRSV, protective effect of intranasal vaccination compared to an unvaccinated control group was confirmed in two studies [106,108].…”
Section: Specific Prevention (Vaccination)mentioning
confidence: 91%
“…Vaccination of newborn calves, especially in the presence of maternal antibodies, poses the same challenges as described for BRSV vaccination and is in the focus of current research [111]. Intranasal vaccination of seronegative newborn calves decreases clinical signs in a challenge trial [107]. However, the situation is complicated by the potential for establishment of seronegative latent carriers in calves with specific maternal antibodies through field virus infection as well as through vaccination with modified-live vaccines [112,113].…”
Section: Specific Prevention (Vaccination)mentioning
confidence: 99%
“…Virus neutralizing antibody titers against BToV in paired sera from affected cows were measured using HRT-18 cells and the BToV strain Aichi/2004 [16]. Virus neutralization (VN) tests were also conducted for bovine viral diarrhea (BVDV) type 1, bovine adenovirus type 3 (BAdV-3), bovine herpesvirus 1 (BHV-1), and bovine respiratory syncytial virus (BRSV) as described previously [36]. Antibody titers against BCV, adenovirus type 7 (BAdV-7), and bovine parainfluenza virus type 3 (BPIV-3) were determined by hemagglutination inhibition (HI) tests [20].…”
Section: Virus-neutralization and Hemagglutination Inhibition Testsmentioning
confidence: 99%
“…Because of the similarities between HRSV and BRSV, it should be possible to gain insight regarding factors that impact safety, efficacy, and duration of immunity in individuals vaccinated either in the presence or absence of circulating neutralizing antibodies using the BRSV model. Many published studies have shown that commercially available BRSV vaccines can induce protection against experimentally induced or naturally occurring BRSV disease (Durham and Hassard, 1990;Ellis et al, 2001;Van Donkersgoed et al, 1990b;Vangeel et al, 2007b;Verhoeff and van Nieuwstadt, 1984;West et al, 1999b;Xue et al, 2010).…”
Section: Vaccines For Brsvmentioning
confidence: 99%
“…Although BRSV vaccine ERD has been well-studied, extensive research and clinical experience indicate that BRSV vaccination can be safe and effective (Ellis et al, 1995;Ellis et al, 2005;Van Donkersgoed et al, 1990a;Vangeel et al, 2007a;Vangeel et al, 2009;Verhoeff and van Nieuwstadt, 1984;West et al, 1999b;Xue et al, 2010). In studies of resistance to experimental challenge, vaccination of calves with low or absent concentrations of serum neutralizing antibodies can protect them from virulent challenge.…”
Section: Vaccines For Brsvmentioning
confidence: 99%